Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/20/2023
Clover, Adimmune Tie Up to Commercialize Quadrivalent Seasonal Flu Vac...
2/13/2023
Clover Launches COVID-19 Booster Vaccine in China
2/8/2023
After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
1/31/2023
Chinese Vaccine Market to Surpass $12.16 Billion by 2027: New Report
1/25/2023
Pharma Cos That Develop Vaccines With Efficacy Against Omicron Variant...
1/19/2023
After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
1/18/2023
Moderna in Active Discussions with China to Supply COVID Vaccines
1/12/2023
Fosun Sees Surge in Demand from Mainland Chinese for Omicron-focused B...
12/28/2022
Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
12/27/2022
Mainland Chinese May Now Get BioNTech COVID-19 Vaccines in Hong Kong...
12/22/2022
NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
12/21/2022
BioNTech Sends First Batch of Vaccine to China for German Residents Th...
12/13/2022
China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
12/9/2022
China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
12/8/2022
China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
11/15/2022
WuXi Vaccines Buys Harbour BioMed China Facility
11/14/2022
BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
11/6/2022
China to Approve BioNTech's Covid-19 Vaccine for Foreigners with Pathw...
10/26/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/9/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/6/2022
AIM Vaccine Launches IPO on the Main Board of SEHK
10/4/2022
Moderna Refuses Chinese Request to Hand Over mRNA Technology, Risking ...
9/22/2022
Moderna 'Eager' to Collaborate with China on Supplying COVID Vaccines
9/16/2022
Competition Intensifies as More Chinese Regions Embarks on Free HPV Va...
8/31/2022
BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
8/24/2022
Chinese Vaccine Regulatory System Passes New WHO Assessment for ML3 Ra...
8/2/2022
China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...
7/22/2022
Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...
7/13/2022
Korea's Orion Holdings Agrees to Build A Tuberculosis Vaccine Plant in...
6/13/2022
Gavi: Chinese Vaccine to Play Major Role in Future Health Challenges
Page:
4
/
22
Total number of articles:
644
:
[First]
[<<]
[2]
[3]
[4]
[5]
[6]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit